Brain metabolic pattern analysis using a magnetic resonance spectra classification software in experimental stroke.

Background: Magnetic resonance spectroscopy (MRS) provides non-invasive information about the metabolic pattern of the brain parenchyma in vivo. The SpectraClassifier software performs MRS pattern-recognition by determining the spectral features (metabolites) which can be used objectively to classif...

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Neuroscience Vol. 18; pp. 1 - 11
Autores principales: Jiménez-Xarrié, Elena, Davila, Myriam, Paula Candiota, Ana, Delgado-Mederos, Raquel, Ortega-Martorell, Sandra, Juliú-Sapé, Margarida, Arús, Carles, Martí-Fábregas, Joan, Candiota, Ana Paula, Julià-Sapé, Margarida, Martí-Fàbregas, Joan
Formato: research Journal Article
Publicado: BioMed Central 1/13/2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=120728947&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 120728947
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14712202
        1CI8
      jtl: BMC Neuroscience
      issn: 14712202
      maglogo: N
    pubinfo:
      dt: 1/13/2017
      vid: 18
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        120728947
        120728947
        NLM28086802
        120728947
        10.1186/s12868-016-0328-x
        NLM28086802
        120728947
      ppf: 1
      ppct: 10
      formats:
      tig:
        atl: Brain metabolic pattern analysis using a magnetic resonance spectra classification software in experimental stroke.
      aug:
        au:
          Jiménez-Xarrié, Elena
          Davila, Myriam
          Paula Candiota, Ana
          Delgado-Mederos, Raquel
          Ortega-Martorell, Sandra
          Juliú-Sapé, Margarida
          Arús, Carles
          Martí-Fábregas, Joan
          Candiota, Ana Paula
          Julià-Sapé, Margarida
          Martí-Fàbregas, Joan
        affil: Stroke Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain
      sug:
        subj:
          Magnetic Resonance Spectroscopy
          Image Processing, Computer Assisted Methods
          Software
          Cerebral Ischemia Classification
          Stroke Classification
          Brain Metabolism
          Inositol Metabolism
          Brain
          Lactic Acid Metabolism
          Metabolism
          Cerebral Ischemia
          Cerebral Ischemia Metabolism
          Creatine Metabolism
          Rats
          Sensitivity and Specificity
          Biochemistry Methods
          Stroke Metabolism
          Animal Studies
          Lipid Metabolism, Inborn Errors
          Stroke
      ab: Background: Magnetic resonance spectroscopy (MRS) provides non-invasive information about the metabolic pattern of the brain parenchyma in vivo. The SpectraClassifier software performs MRS pattern-recognition by determining the spectral features (metabolites) which can be used objectively to classify spectra. Our aim was to develop an Infarct Evolution Classifier and a Brain Regions Classifier in a rat model of focal ischemic stroke using SpectraClassifier.Results: A total of 164 single-voxel proton spectra obtained with a 7 Tesla magnet at an echo time of 12 ms from non-infarcted parenchyma, subventricular zones and infarcted parenchyma were analyzed with SpectraClassifier ( http://gabrmn.uab.es/?q=sc ). The spectra corresponded to Sprague-Dawley rats (healthy rats, n = 7) and stroke rats at day 1 post-stroke (acute phase, n = 6 rats) and at days 7 ± 1 post-stroke (subacute phase, n = 14). In the Infarct Evolution Classifier, spectral features contributed by lactate + mobile lipids (1.33 ppm), total creatine (3.05 ppm) and mobile lipids (0.85 ppm) distinguished among non-infarcted parenchyma (100% sensitivity and 100% specificity), acute phase of infarct (100% sensitivity and 95% specificity) and subacute phase of infarct (78% sensitivity and 100% specificity). In the Brain Regions Classifier, spectral features contributed by myoinositol (3.62 ppm) and total creatine (3.04/3.05 ppm) distinguished among infarcted parenchyma (100% sensitivity and 98% specificity), non-infarcted parenchyma (84% sensitivity and 84% specificity) and subventricular zones (76% sensitivity and 93% specificity).Conclusion: SpectraClassifier identified candidate biomarkers for infarct evolution (mobile lipids accumulation) and different brain regions (myoinositol content).
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N